Biogen said on Tuesday that it will replace its chief executive and effectively give up on marketing a high-profile Alzheimer’s drug that has been a commercial failure since its controversial…
Tag: Aduhelm
Alzheimer’s Drug Aduhelm Faces Crucial Medicare Decision
Posts supporting coverage include comments from people who have consulted for Biogen, like Dr. Jeffrey Cummings, a research professor in the department of brain health at the University of Nevada…